877370

Novo Nordisk Inc. — FEI 2244771

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 15, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plainsboro, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)